Albireo Pharma is a rare disease company focused on the development of novel bile acid modulators to treat rare pediatric and adult liver diseases. Albireo s lead product, BylvayTM (odevixibat), was approved by the U.S. FDA as the first drug for the treatment of pruritus...
Read More